American Association for Cancer Research

Poster Session A

Poster Session A
Monday, June 7
5:00 p.m.-7:30 p.m.

In alphabetical order, not board assignment order

  • Assessment of multiple types of DNA damage in human placentas from smoking and nonsmoking women in the Czech Republic. M. Margaret Pratt1, Leon C. King2, Linda D. Adams2, Kaarthik John1, Paul Sirajuddin1, Ofelia A. Olivero1, David K. Manchester3, Radim J. Sram4, David M. DeMarini2, Miriam C. Poirier1. 1National Cancer Institute, Bethesda, MD, 2U.S. Environmental Protection Agency, Research Triangle Park, NC, 3University of Colorado, Denver, CO, 4Academy of Sciences of the Czech Republic, Prague, Czech Republic.
  • Association between genetic variants in the insulin-like growth factor (IGF) pathway and the risk of advanced colorectal adenoma. Ying Gao, Hormuzd Katki, Barry Graubard, Neil Caporaso, Michael Pollak, Michael Martin, Yuzhan Tao, Laurie Burdett, Robert Scheon, Timothy Church, Richard Hayes, Stephen Chanock, Mark Greene, Sonja Berndt. National Cancer Institute, Rockville, MD.
  • Association of dietary and plasma carotenoids with circulating F2-isoprostanes in a pooled case-control study of incident colorectal adenomas. Chiranjeev Dash1, Michael Goodman1, Myron D. Gross2, Roberd M. Bostick1. 1Rollins School of Public Health, Emory University, Atlanta, GA, 2University of Minnesota Medical School, University of Minnesota, Minneapolis, MN.
  • Biomarkers of exposure to asphalt and their relationship to oxidative DNA damage among roofers in South Florida. Berrin Serdar. Florida International University, Miami, FL.
  • BRCA1 and BRCA2 sequence variants in Algerian breast/ovarian cancer families. Farid Cherbal1, Dounia Amet Errahmane Houamel1, Gaelle Benais-Pont2, Rabah Bakour1, Saida Adane3, Kada Boualga4, Philippe Maillet2. 1Unit of Genetics, LMCB, FBS, USTHB, Algiers, Algeria; 2Laboratory of Molecular Oncology, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland; 3Central Hospital of Algiers, Algiers, Algeria; 4Anti Cancer Center, Blida, Algeria.
  • Candidate biomarkers for pancreatic cancer evaluated using antibody-lectin sandwich arrays in multiple serum sample sets. Tingting Yue1, Lin Li2, Michelle A. Anderson3, Diane M. Simeone3, Ziding Feng2, Randall E. Brand4, Brian B. Haab1. 1Van Andel Institute, Grand Rapids, MI, 2Fred Hutchinson Cancer Research Center, Seattle, WA, 3University of Michigan, Ann Arbor, MI, 4University of Pittsburgh, Pittsburgh, PA.
  • Circulating cytokines and epithelial ovarian cancer. Tess V. Clendenen1, Eva Lundin2, Anne Zeleniuch-Jacquotte1, Karen L. Koenig1, Annekatrin Lukanova3, Anna Lokshin4, Goran Hallmans2, Vittorio Krogh5, Adele Marrangioni4, Brian M. Nolen4, Alan A. Arslan1. 1New York University, Langone Medical Center, New York, NY, 2Umeå University, Umeå, Sweden, 3Cancer Research Center (DKFZ), Heidelberg, Germany, 4University of Pittsburgh Cancer Institute, Pittsburgh, PA, 5National Cancer Institute, Milan, Italy.
  • Cranberry proanthocyanidins induce cell death in acid-resistant esophageal adenocarcinoma cells. Amy Exum1, Bree Zeyzus-Johns1, Amy B. Howell2, Laura A. Kresty1. 1The University of Miami Miller School of Medicine, Miami, FL, 2Rutgers University, Chatsworth, NJ.
  • C-reactive protein for the early detection of cancer and cancer prognosis. Mieke Van Hemelrijck1, Lars Holmberg1, Niklas Hammar2, Hans Garmo1, Elisa Binda1, Adrian Hayday1, Mats Lambe2, Göran Walldius2, Ingmar Jungner2. 1King's College London, London, United Kingdom, 2Karolinska Institute, Stockholm, Sweden.
  • Dietary intake of isothiocyanate-rich foods and lung cancer risk: A nested case-control study matched on cigarette smoking. Tram Kim Lam1, Ingo Ruczinski2, Kathy Helzlsouer3, Yin Yao Shugart2, Kelly E. Li4, Laura E. Caulfield2, Anthony J. Alberg5. 1National Cancer Institute, Rockville, MD, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Mercy Medical Center, Baltimore, MD, 4Applied Biosystem, Foster City, CA, 5Hollings Cancer Center and Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, SC.
  • Differential methylation of multiple epigenetic markers in peripheral blood leukocyte DNA: A potential screening measure for pancreatic cancer at all stages. Katrina S. Pedersen, William R. Bamlet, Mariza de Andrade, Ann L. Oberg, Gloria M. Petersen, Liang Wang. Mayo Clinic, Rochester, MN.
  • Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free females. Ekaterina S. Kuligina, Tatiana V. Gorodnova, Grigory A. Yanus, Anna S. Katanugina, Svetlana N. Abysheva, Alexandr V. Togo, Evgeny N. Imyanitov. N. N. Petrov Institute of Oncology, St. Petersburg, Leningrad, Russian Federation.
  • Early life body size and adult IGF-1 and IGFBP-3 levels. Elizabeth M. Poole, Shelley S. Tworoger, Heather J. Baer. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
  • Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: A randomized, controlled clinical trial. Myfanwy H. Hopkins, Dean P. Jones, Roberd M. Bostick. Emory University, Atlanta, GA.
  • Epitope polymorphisms in hepatitis B virus, long-term dynamics of viral load, and subsequent risk of hepatocellular carcinoma. Chi-Jung Huang1, Chia-Ying Lan1, Li-Ching Chang1, Chih-Feng Wu1, Chih-Lin Lin2, Chun-Jen Liu3, Ming-Whei Yu1. 1Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan, 2Taipei City Hospital, Taipei, Taiwan, 3National Taiwan University Hospital, Taipei, Taiwan.
  • Estrogen metabolism and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Barbara J. Fuhrman1, Catherine Schairer1, Mitchell H. Gail1, Jennifer Boyd-Morin2, Laura Y. Sue1, Saundra S. Buys3, Claudine Isaacs4, Timothy D. Veenstra5, Larry K. Keefer5, Xia Xu5, Christine D. Berg1, Robert N. Hoover1, Regina G. Ziegler1. 1National Cancer Institute, Bethesda, MD, 2Information Management Services, Inc., Silver Spring, MD, 3University of Utah, Salt Lake City, UT, 4Georgetown University, Washington, DC, 5National Cancer Institute, Frederick, MD.
  • Evaluating multiple exposures in epidemiology studies using shrinkage estimators: Application to the study of nevi in children. Jaya M. Satagopan1, Qin Zhou1, Susan A. Oliveria1, Stephen W. Dusza1, Martin A. Weinstock2, Marianne Berwick3, Allan C. Halpern1. 1Memorial Sloan-Kettering Cancer Center, New York, NY, 2Brown University, Providence, RI, 3University of New Mexico, Albuquerque, NM.
  • Genetic polymorphisms in vitamin D pathway genes and breast cancer risk: A report from the Shanghai Breast Cancer Study. Tsogzolmaa Dorjgochoo1, Xiao-Ou Shu1, Wei Lu2, Jirong Long1, Qiuyin Cai1, Ying Zheng2, Kai Gu2, Yu-Tang Gao3, Wei Zheng1. 1Vanderbilt University, Nashville, TN, 2Shanghai Institute of Preventive Medicine, Shanghai, China, 3Shanghai Cancer Institute, Shanghai, China.
  • Genetic variation and methylation of ESR1, ESR2, PGR, and AR in endometrial cancer. Hannah P. Yang1, Montserrat Garcia-Closas1, Mark E. Sherman1, Keith J. Killian2, Lisa Adams2, Louise A. Brinton1, Jolanta Lissowska3, Aileen Burke1, Stephen Chanock1, Stephen Hewitt2, Paul Meltzer2, Nicolas Wentzensen1. 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, 2Center for Cancer Research, National Cancer Institute, Bethesda, MD, 3M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Genome-wide characterization of gene expression and DNA copy number alterations in prostate cancer. Elisabeth Feik1, Norbert Schweifer2, Wolfgang Sommergruber2, Christian Haslinger2, Gerhard Fuehrlinger1, Stephan Madersbacher3, Michael Micksche1, Andrea Gsur1. 1Institute of Cancer Research, Medical University of Vienna, Vienna, Austria, 2Boehringer Ingelheim RCV, Vienna, Austria, 3Donauspital, Vienna, Austria.
  • ICI182,780 induces P-cadherin upregulation in breast cancer cells through histone modifications at the promoter level: The role of C/EBPbeta in CDH3 gene activation. André Albergaria1, Ana Sofia Ribeiro1, Sandra Pinho2, Fernanda Milanezi1, Vítor Carneiro3, Bárbara Sousa1, Sónia Sousa1, Carla Oliveira1, José Carlos Machado1, Raquel Seruca1, Joana Paredes1, Fernando Schmitt1. 1IPATIMUP, Porto, Portugal; 2Imperial College of London, London, United Kingdom; 3Hospital Divino Espirito Santo, Ponta Delgada, Portugal.
  • Initial results from a GWAS of lung cancer among never-smoking females in Asia and plans for expansion within the Female Lung Cancer Consortium in Asia. Qing Lan1, Chao Agnes Hsiung2, Yun-Chul Hong3, Dean Hosgood1, I-Shou Chang2, Nilanjan Chatterjee1, Brennan Paul4, Wei Zheng5, Tangchun Wu6, Jae Yong Park7, Yeul Hong Kim8, Hongbing Shen9, Adeline Seow10, Meredith Yeager1, Neil Caporaso1, Maria Teresa Landi1, Margaret Tucker1, Young Tae Kim3, Xiao Ou Shu11, Paolo Boffetta12, Joseph F. Fraumeni, Jr.1, Stephen Chanock1, Pan-Chyr Yang13, Nathaniel Rothman1, Dongxin Lin11. 1National Cancer Institute, Rockville, MD, 2National Health Research Institutes, Zhunan, Taiwan, China, 3Seoul National University College of Medicine, Seoul, Republic of Korea, 4IARC, Lyon, France, 5Vanderbilt University School of Medicine, Nashville, TN, 6Huazhong University of Science and Technology, Wuhan, China, 7Kyungpook National University, Daegu, Republic of Korea, 8Korea University College of Medicine, Seoul, Republic of Korea, 9Nanjing Medical University, Nanjing, China, 10National University of Singapore, Singapore, 11Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China, 12Mt. Sinai School of Medicine, New York, NY, 13National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Methylation profiles in head and neck cancer. Semra Demokan1, Zubeyde Yalniz1, Yusufhan Suoglu2, Murat Ulusan2, Nejat Dalay1. 1Istanbul University, Oncology Institute, Istanbul, Turkey; 2Istanbul University, Istanbul Faculty of Medicine, Department of Otolaryngology, Head & Neck Surgery, Istanbul, Turkey.
  • Mitochondrial DNA copy number and risk of gastric cancer: A report from the Shanghai Women’s Health Study. Linda M. Dong1, Andrea Baccarelli2, Xiao-Ou Shu3, Yu-Tang Gao4, Bu-Tian Ji1, Gong Yang3, Hong-Lan Li4, Nathaniel Rothman1, Wei Zheng3, Wong-Ho Chow1. 1National Cancer Institute, Bethesda, MD, 2IRCCS Ca’ Granda Policlinico Foundation and University of Milan, Milan, Italy, 3Vanderbilt Epidemiology Center, Nashville, TN, 4Shanghai Cancer Institute, Shanghai, China.
  • New insights into heterogenous ribonucleoprotein K expression and accumulation in oral squamous cell carcinoma. Cristiana B. Garcia1, Luciana O. Almeida1, Renata N. Goto1, Camila M. Sayuri1, Eloiza H. Tajara2, Research Head and Neck Genome3, Lewis J. Greene4, J. Silvio Gutkind5, Carlos Curti1, Andreia M. Leopoldino1. 1Faculdade de Ciências Farmaceuticas de RIbeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil, 2Faculdade de Medicina de São José do Rio Preto, São José Do Rio Preto, SP, Brazil, 3GENCAPO, FAPESP, Sao Paulo, SP, Brazil, 4Centro de Química de Proteínas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil, 5NIDCR, National Institute of Health, Bethesda, MD.
  • Oxidative damage to placental DNA, air pollution, genetic polymorphisms and pregnancy outcomes. Pavel Rossner, Jr., Nana Tabashidze, Miroslav Dostal, Zuzana Novakova, Irena Chvatalova, Milada Spatova, Radim J. Srám. Inst. of Experimental Medicine, Prague, Czech Republic.
  • Polymorphisms in microRNA biogenesis genes represent biologically plausible ovarian cancer susceptibility loci. Jennifer Permuth-Wey1, Donghwa Kim1, Bill Ge1, Ya-Yu Tsai1, Hui-Yi Lin1, Johnathan M. Lancaster1, William Kong1, Judith Ebbert-Syfrett1, Gregory Bloom1, Zhihua Chen1, Y. Ann Chen1, Heather Stockwell2, Dagne Getachew2, Edwin Iversen3, Harvey Risch4, Jill Barnholtz-Sloan5, Julie M. Cunningham6, Robert A. Vierkant6, Brooke Fridley6, David Fenstermacher1, Rebecca Sutphen2, John McLaughlin7, Steven A. Narod8, Ellen L. Goode6, Joellen M. Schildkraut3, Catherine M. Phelan1, Jin Q. Cheng1, Thomas A. Sellers1. 1Moffitt Cancer Center, Tampa, FL, 2University of South Florida, Tampa, FL, 3Duke University School of Medicine, Durham, NC, 4Yale University, New Haven, CT, 5Case Comprehensive Cancer Center, Cleveland, OH, 6Mayo Clinic College of Medicine, Rochester, MN, 7University of Toronto, Toronto, ON, Canada, 8Women’s College Hospital, Toronto, ON, Canada.
  • Pooled analysis of MSR1 variants and prostate cancer risk. Wen-Yi Huang1, Kim Danforth1, Richard B. Hayes2, Ann W. Hsing1, Charles Rabkin1, Stephen J. Chanock1, Sonja I. Berndt1. 1National Cancer Institute, Bethesda, MD, 2New York University School of Medicine, New York, NY.
  • Promoter methylation in prostate cancer: A pilot study. Lissette Delgado-Cruzata, Karina Gonzalez, Regina Santella, Shen Jing. Mailman School of Public Health, New York, NY.
  • PTMA, a potential biomarker and independent poor prognosticator for head and neck oral squamous cell carcinoma. Satyendra C. Tripathi1, Ajay Matta2, Jatinder Kaur1, Shyam S. Chauhan1, Nootan K. Shukla1, Siddhartha D. Gupta1, K. W. Michael Siu2, Ranju Ralhan3. 1All India Institute of Medical Sciences, New Delhi, Delhi, India, 2Center for Research in Mass Spectrometry, York University, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada.
  • Tamoxifen-DNA adduct formation in Erythrocebus patas monkeys and humans. Elena E. Hernandez-Ramon1, Ruth A. Woodward1, Miriam C. Poirier2, Kaarthik John2. 1National Institute of Child Health and Human Development, Bethesda, MD, 2National Cancer Institute, Bethesda, MD.
  • The association between apolipoprotein A-I and prostate cancer in the Swedish AMORIS study. Mieke Van Hemelrijck1, Göran Walldius2, Ingmar Jungner2, Niklas Hammar2, Hans Garmo1, Elisa Binda1, Adrian Hayday2, Mats Lambe2, Lars Holmberg1. 1King's College London, London, United Kingdom, 2Karolinska Institute, Stockholm, Sweden.
  • Variants of genes in the lipid metabolism pathway modify the effect of pesticides on prostate cancer risk in the Agricultural Health Study cohort. Gabriella Andreotti1, Stella Koutros1, Sonja Berndt1, Kathryn Barry Hughes1, Lifang Hou2, Jane Hoppin3, Dale Sandler3, Jay Lubin1, Laurie Burdette4, Jeffrey Yuenger4, Meredith Yeager4, Laura Beane Freeman1, Michael Alavanja1. 1National Cancer Institute , Rockville, MD, 2Northwestern University, Chicago, IL, 3National Institute of Environmental Health Sciences, Research Park, NC, 4Core Genotyping Facility, Gaithersburg, MD.
Poster Session A Poster Session B